Loading...
Loading...
LocalAISource · Chicago, IL
Updated May 2026
Chicago is one of North America's largest insurance, pharma, and aerospace hubs. Allstate operates its headquarters and claims network from the city, processing millions of property-and-casualty claims annually. Takeda Pharmaceutical runs global clinical trials and R&D operations from its North American center here. Boeing's defense division operates massive supply-chain and manufacturing-documentation systems. For automation teams, Chicago represents enterprise-scale RPA: the complexity is not in individual workflows but in orchestrating thousands of connected processes across risk-averse, regulated industries. A partner who can navigate enterprise governance, work with security-conscious IT organizations, and scale pilots to production across multiple business units is essential. LocalAISource connects Chicago enterprise operations, compliance, and innovation leaders with automation specialists experienced in insurance claims at scale, pharmaceutical clinical operations, and aerospace supply-chain compliance.
Allstate processes 1M+ property-and-casualty claims annually. Each claim follows a complex workflow: intake, triage (small claim vs. major loss vs. fraud flag), estimation, adjuster assignment, repair coordination, and settlement. Claims can be denied for policy language reasons, partial coverage due to deductibles or limits, or fraud detection (staged accidents, inflated damage claims). RPA automates the routine: intake the claim (via API, mobile app, or phone transcript), extract key fields (claimant, coverage type, claim amount, injury type), validate basic policy coverage in real-time, route to appropriate adjuster pool (small claims fast-track vs. major-loss team), and trigger fraud-screening workflows. The fraud piece is sophisticated: RPA feeds claim data into fraud models, cross-references against previous claims (same claimant, similar losses = elevated risk), pulls social media and public records, and flags for human investigator review. For ~20% of claims that are routine and low-risk, RPA can approve and settle in 24-48 hours; for the remaining 80%, it accelerates the adjuster's work by pre-populating data and flagging anomalies.
Takeda runs dozens of active clinical trials across North America, enrolling thousands of patients. Each patient generates a complex documentation trail: informed consent, safety assessments, protocol deviations, adverse-event reports, and regulatory notifications. These must be logged in the electronic data capture (EDC) system, cross-checked against inclusion/exclusion criteria, and escalated to study teams and regulatory bodies if safety thresholds are exceeded. Manual routing is slow and error-prone. RPA can integrate the EDC system, the adverse-event database, and the regulatory notification platform into a single workflow: when a patient safety event is logged, the RPA checks the patient's enrollment protocol and prior events, determines if this is a reportable adverse event, and if so, automatically generates the regulatory notification for the study team's review and signature. For protocol deviations, the RPA flags the deviation, checks if it affects patient safety or data integrity, and routes for protocol committee review. That orchestration accelerates trial timelines and ensures regulatory compliance.
Boeing's defense operations source thousands of parts and subsystems from dozens of Tier-1 and Tier-2 suppliers. Each component must have documented configuration (revision level, serial number, manufacturing lot), proof of traceability (where it came from, how it was tested), and compliance with defense specifications (MIL-SPEC standards, AS9100 quality management). Documentation requirements are massive: build-to-print drawings, test reports, material certs, inspection records, and deviation reports. RPA can integrate supplier portals, the part-configuration database, test-results systems, and the supply-chain documentation repository into a single intake workflow: when a supplier submits a component for delivery, the RPA reads the component identification, pulls the build specification, checks that all required documentation is submitted, validates against specification requirements, and either releases it for production or flags missing/non-conforming documentation for the supplier to correct. That automation accelerates production without sacrificing compliance.
The RPA should NOT make the fraud determination; that requires human investigation and judgment. Instead, design the RPA to gather signals: cross-check against previous claims by the same claimant, run the claim amount through a statistical model (is it an outlier for this claim type in this geography?), pull public records to see if the claimant has other active claims, and check social media for inconsistencies (e.g., claiming back injury while posting photos at a wedding). The RPA flags the claim with these signals for an investigator, who then decides whether to approve, investigate, or deny. This design automates the investigation intake (which takes hours manually) without replacing human judgment (which is legally and ethically required).
Allstate's goal is to reduce claims cycle time (time from filing to settlement) by 20-30% and reduce adjuster processing time per claim by 25-35%. If the average claim currently takes 8 weeks to settle and RPA cuts that to 5-6 weeks for routine claims, customers are happier and Allstate saves on interest costs and claims reserves. At 1M+ claims annually, a 30% efficiency improvement on adjuster work hours saves roughly 40-50 FTE, which is a payoff worth tens of millions annually. Timeline to payback is typically 12-18 months because claims RPA requires significant upfront compliance and governance work.
Clinical trial data is subject to HIPAA and international data-protection regulations (GDPR in EU trial sites). RPA workflows must enforce those constraints: patient identifiers must be handled via pseudonym-substitution systems (RPA works with patient ID, not name/SSN), audit trails must be immutable (every RPA action logged with timestamp), and data residency rules must be respected (EU patient data cannot leave EU systems). This design means your RPA cannot be a simple cloud service; it needs to run either on-premises or in a compliant cloud environment (AWS GovCloud, Azure Government, etc.). A pharma-experienced partner will build this compliance into the design from day one, not tack it on later.
The RPA can validate that the submitted documentation matches the required checklist (e.g., 'build-to-print drawing, test report, traceability cert, material cert = 4 of 4 documents submitted'). But validating that the test report actually demonstrates compliance with MIL-SPEC (e.g., checking that the tensile strength is within spec) requires engineering judgment and possible physical inspection. Design the RPA to enforce the process (all docs present, proper format, legible signatures) and escalate to a quality engineer for technical validation. As a secondary layer, the RPA can automatically check numeric values in test reports against spec bounds and flag outliers, but the engineer must still review.
At Allstate and Boeing's scale, you need a central RPA Center of Excellence (CoE) that sets standards, maintains the shared platform (whether that is UiPath, Automation Anywhere, or Blue Prism), and approves business-unit RPA initiatives. The CoE should maintain a repository of reusable components (common integrations, compliance checks, escalation templates), a runbook of best practices, and a prioritized pipeline for new RPA work. Without that governance, business units deploy RPA independently, leading to duplicate work, security gaps, and skill fragmentation. A good automation partner will advise on CoE structure, not just deliver individual RPA solutions.
Join Chicago, IL's growing AI professional community on LocalAISource.